Last reviewed · How we verify

NCT05737225

Regional Anesthesia for Percutaneous Transluminal Angioplasty

Completed Last updated 20 December 2023
What this trial tests

trial testing Near Infrared Spectroscopy (NIRS) in Peripheral Artery Occlusive Disease in 70 participants. Completed in 1 May 2023.

Timeline
24 September 2022
Primary endpoint
17 April 2023
1 May 2023

Quick facts

Lead sponsorGazi University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment70
Start date24 September 2022
Primary completion17 April 2023
Estimated completion1 May 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gazi University

Who can join

Adults 18 to 99, any sex, with Peripheral Artery Occlusive Disease or Percutaneous Transluminal Angioplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the effects of regional anesthesia method applied in patients who will undergo percutaneous transluminal angioplasty for lower extremity revascularization will be investigated comparatively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Near Infrared Spectroscopy (NIRS)

Trials testing the same drug.

Other recruiting trials for Peripheral Artery Occlusive Disease

Currently open trials in the same condition.

Other Gazi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05737225.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing